smad8 (Santa Cruz Biotechnology)
Structured Review

Smad8, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 37 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/smad8/Smad8+Antibody/pm40076910-176-62-63
Average 93 stars, based on 37 article reviews
Images
1) Product Images from "Expression Patterns of SMAD1-8 in the Peripheral Facial Nerve Following Compressive Nerve Injury or Axotomy."
Article Title: Expression Patterns of SMAD1-8 in the Peripheral Facial Nerve Following Compressive Nerve Injury or Axotomy.
Journal: International journal of molecular sciences
doi: 10.3390/ijms26052291
Figure Legend Snippet: Figure 2. Differential expression of SMAD1–8 proteins in the peripheral facial nerve following injury. Western blot analysis of SMAD1–8 protein levels in the peripheral facial nerve at 2 and 12 weeks post injury induced by compression or axotomy. At 2 weeks, compression injury led to a significant increase in SMAD2 expression. By 12 weeks, SMAD7 and SMAD8 expression were elevated in the Compression group. In contrast, axotomy resulted in significant upregulation of SMAD1, SMAD2, SMAD3, SMAD4, SMAD6, SMAD7, and SMAD8 at both 2 and 12 weeks; no change in SMAD5 expression was observed in either injury model. The complete gel images are available in Supplementary Figures S1 and S2 for reference. Data are presented as means ± S.D., with a sample size of n = 3 per group (* p < 0.05 vs. Sham group). Abbreviations: wks, weeks.
Techniques Used: Quantitative Proteomics, Western Blot, Expressing
Related Articles
Incubation:Article Title: BMP-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-β/Smad and BMP-7/Smad signaling pathway. Article Snippet: Objective: To investigate the anti-fibrotic effects and possible mechanisms of bone morphogenetic protein-7 (BMP-7) on silica induced fibrosis in RLE-6TN cells, and compare the preventive treatment of experimental silicosis with BMP-7 with therapeutic treatment of silicosis in vitro models.. Methods: RLE-6TN cells were incubated with the supernatant of RAW264.7, treated by 50 mg/mL silica in either presence or absence of BMP-7 in different phases.. Morphological changes and the cellular woundhealing assays were used to evaluate the process of EMT. |
